We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+5.03%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$613M
AUM Growth
+$11.1M
Cap. Flow
+$98.2M
Cap. Flow %
16.02%
Top 10 Hldgs %
52.71%
Holding
630
New
243
Increased
56
Reduced
99
Closed
199

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$60.6M
2
ALBO
Albireo Pharma Inc
ALBO
+$17.5M
3
AVPT icon
AvePoint
AVPT
+$14.1M
4
SST icon
System1
SST
+$10.2M
5
MCD icon
McDonald's
MCD
+$10M

Top Sells

Rank Stock Value
1
CCL icon
Carnival Corporation Ltd
CCL
+$24.2M
2
BLU
BELLUS Health Inc.
BLU
+$16.7M
3
ABUS icon
Arbutus Biopharma
ABUS
+$11.7M
4
NKLAW
Nikola Corporation Warrant expiring 6/3/2025
NKLAW
+$11M
5
LGVW.U
Longview Acquisition Corp. Units, each consisting of one share of Class A common stock, and one-thir
LGVW.U
+$5.79M

Sector Composition

Rank Sector Weight
1 Healthcare 14.03%
2 Consumer Discretionary 13.24%
3 Financials 8.37%
4 Technology 6.29%
5 Industrials 3.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MYOK
251
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$115K 0.02%
+844
New +$89.7K
AMRN
252
PUT
Amarin Corp
AMRN
$296M
$111K 0.02%
8,845
+7,720
+686% +$925K
ROCHU
253
DELISTED
Roth CH Acquisition I Co. Unit
ROCHU
$107K 0.02%
+10,000
New +$105K
IFF icon
254
PUT
International Flavors & Fragrances
IFF
$21.7B
$106K 0.02%
+37,200
New +$4.63M
FIT
255
CALL
DELISTED
Fitbit, Inc. Class A common stock
FIT
$104K 0.02%
388,700
-479,200
-55% -$3.11M
BBBY
256
CALL
DELISTED
Bed Bath & Beyond Inc
BBBY
$102K 0.02%
35,500
– –
COF icon
257
CALL
Capital One
COF
$134B
$101K 0.02%
+22,100
New +$1.48M
DCPH
258
CALL
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$101K 0.02%
+15,000
New +$735K
YAC
259
DELISTED
Yucaipa Acquisition Corporation Class A Ordinary Shares
YAC
$101K 0.02%
+10,163
New +$101K
USB icon
260
CALL
US Bancorp
USB
$100B
$99K 0.02%
+254,900
New +$9.33M
LSACW
261
DELISTED
LifeSci Acquisition Corp. Warrant
LSACW
$98K 0.02%
+64,000
New +$56.9K
PPLI
262
PUT
People Inc
PPLI
$2.97B
$95K 0.02%
+55,514
New +$3.81M
NVVEW
263
DELISTED
Newborn Acquisition Corp Warrant
NVVEW
$95K 0.02%
328,689
-58,800
-15% -$10.2K
GWPH
264
PUT
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$93K 0.02%
+7,500
New +$863K
FITB
265
Fifth Third Bancorp
FITB
$52.2B
$92K 0.02%
+4,316
New +$86.9K
MIST icon
266
Milestone Pharmaceuticals
MIST
$158M
$88K 0.01%
+11,990
New +$85.9K
UNP icon
267
PUT
Union Pacific
UNP
$174B
$88K 0.01%
+32,400
New +$6.02M
AVYA
268
CALL
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
$88K 0.01%
24,000
– –
FIT
269
PUT
DELISTED
Fitbit, Inc. Class A common stock
FIT
$87K 0.01%
547,700
-233,400
-30% -$1.52M
MRTX
270
CALL
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$85K 0.01%
5,300
-4,700
-47% -$643K
GNW icon
271
Genworth Financial
GNW
$3.7B
$84K 0.01%
+25,000
New +$66.6K
ALXN
272
CALL
DELISTED
Alexion Pharmaceuticals
ALXN
$82K 0.01%
13,500
-25,300
-65% -$2.73M
GME icon
273
PUT
GameStop
GME
$8.44B
$81K 0.01%
+400,000
New +$578K
ASLE icon
274
AerSale
ASLE
$273M
$79K 0.01%
277,050
-72,098
-21% -$741K
FCX icon
275
PUT
Freeport-McMoran
FCX
$96.4B
$77K 0.01%
186,300
-26,200
-12% -$378K
9 10
11
12 13

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q3 2020 Portfolio in Review

As of Q3 2020, Cowen and Company held 630 positions worth $613M, up 1.8% from $601M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Cowen and Company deployed $98.2M of net new capital in Q3 2020, opening 243 new positions and adding to 56 existing holdings. Its largest new stake was Albireo Pharma Inc: 600,000 shares worth $20M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Arbutus Biopharma, an estimated $11.7M trimmed.

  • Cowen and Company's largest Q3 2020 buy was Albireo Pharma Inc: 600,000 shares worth $20M.
  • Cowen and Company added most to Invesco QQQ Trust in Q3 2020, an estimated $60.6M increase.
  • Cowen and Company's biggest Q3 2020 reduction was Arbutus Biopharma, cutting an estimated $11.7M.
  • Cowen and Company fully exited Carnival Corporation Ltd in Q3 2020, selling an estimated $24.2M.
  • Cowen and Company's ten largest holdings make up 53% of its $613M portfolio in Q3 2020.
  • Cowen and Company opened 243 new positions and closed 199 in Q3 2020.
  • Cowen and Company's portfolio value rose 1.8% quarter-over-quarter to $613M.

Based on Cowen and Company's 13F filing for Q3 2020, filed 3 Nov 2020.